There has been an increasing trend in the number of patients with IBD (either CD or UC) in the US, with nearly 70,000 new individuals diagnosed every year; by 2014, an estimated 1.6 million adults were affected [ 4 ].
← all excerpts
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
1
—
—